Related Experiment Video
Updated: Aug 8, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Inverse correlation between N-myc amplification and catecholamine metabolism in children with advanced neuroblastoma
A Nakagawara1, K Ikeda, K Higashi
1Department of Pediatric Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Abstract:
The relationship between urinary excretion of catecholamine and/or its metabolites before the initiation of therapy and the genomic amplification of N-myc of the extirpated primary tumors was studied in 32 patients who had advanced neuroblastoma (stages III and IV). Values of vanillylmandelic acid, homovanillic acid, and noradrenaline excreted in urine were significantly higher in patients with 1 to 10 copies of N-myc (L-group) than in those patients who had more than 10 copies (H-group), whereas values of dopamine in urine were not significantly different between the groups. The ratio of urinary noradrenaline and dopamine was also significantly higher in the L-group. N-myc amplification, urinary excretion of vanillylmandelic acid and the noradrenaline/dopamine ratio significantly affected the prognosis. These data suggest that an inverse regulatory mechanism might be present between the N-myc amplification and catecholamine metabolism in patients who have advanced neuroblastoma, possibly at the level of gene and/or enzyme. These events would influence the prognosis. The main blockade of the metabolism may be in the metabolic processes from dopamine to noradrenaline.
Insights
Advanced neuroblastoma patients with lower N-myc gene copies showed higher urinary catecholamine levels. This suggests a link between N-myc amplification, catecholamine metabolism, and prognosis in neuroblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Neuroblastoma is a pediatric cancer often associated with N-myc gene amplification.
- Catecholamine metabolism is frequently altered in neuroblastoma patients.
- The interplay between N-myc status and catecholamine pathways is not fully understood.
Purpose of the Study:
- To investigate the relationship between N-myc gene amplification and urinary catecholamine metabolite excretion in advanced neuroblastoma.
- To determine if these factors influence patient prognosis.
Main Methods:
- Studied 32 patients with advanced neuroblastoma (stages III-IV).
- Measured urinary excretion of vanillylmandelic acid, homovanillic acid, noradrenaline, and dopamine before therapy.
- Assessed N-myc gene amplification in primary tumors.
Main Results:
- Patients with lower N-myc copies (1-10) had significantly higher urinary vanillylmandelic acid, homovanillic acid, and noradrenaline compared to those with >10 copies.
- Urinary dopamine levels did not differ significantly between groups.
- Higher urinary noradrenaline/dopamine ratio was observed in patients with lower N-myc copies.
- N-myc amplification, urinary vanillylmandelic acid, and the noradrenaline/dopamine ratio were significant prognostic factors.
Conclusions:
- An inverse regulatory mechanism between N-myc amplification and catecholamine metabolism may exist in advanced neuroblastoma.
- This interaction likely influences patient prognosis.
- Metabolic blockade from dopamine to noradrenaline is a potential key pathway.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

